<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">35180021</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>FAEE exerts a protective effect against osteoporosis by regulating the MAPK signalling pathway.</ArticleTitle>
        <Pagination>
          <StartPage>467</StartPage>
          <EndPage>478</EndPage>
          <MedlinePgn>467-478</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2022.2039216</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Ferulic acid ethyl ester (FAEE) is abundant in <i>Ligusticum chuanxiong</i> Hort. (Apiaceae) and grains, and possesses diverse biological activities; but the effects of FAEE on osteoporosis has not been reported.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study investigated whether FAEE can attenuate osteoclastogenesis and relieve ovariectomy-induced osteoporosis via attenuating mitogen-activated protein kinase (MAPK).</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We stimulated RAW 264.7 cells with receptor activator of NF-κB ligand (RANKL) followed by FAEE. The roles of FAEE in osteoclast production and osteogenic resorption of mature osteoclasts were evaluated by tartrate resistant acid phosphatase (TRAP) staining, expression of osteoclast-specific genes, proteins and MAPK. Ovariectomized (OVX) female Sprague-Dawley rats were administered FAEE (20 mg/kg/day) for 12 weeks to explore its potential <i>in vivo</i>, and then histology was undertaken in combination with cytokines analyses.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">FAEE suppressed RANKL-induced osteoclast formation (96 ± 0.88 vs. 15 ± 1.68) by suppressing the expression of osteoclast-specific genes, proteins and MAPK signalling pathway related proteins (p-ERK/ERK, p-JNK/JNK and p-P38/P38) <i>in vitro</i>. In addition, OVX rats exposed to FAEE maintained their normal calcium (Ca) (2.72 ± 0.02 vs. 2.63 ± 0.03, <i>p</i> &lt; 0.05) balance, increased oestradiol levels (498.3 ± 9.43 vs. 398.7 ± 22.06, <i>p</i> &lt; 0.05), simultaneously reduced levels of bone mineral density (BMD) (0.159 ± 0.0016 vs. 0.153 ± 0.0025, <i>p</i> &lt; 0.05) and bone mineral content (BMC) (0.8 ± 0.0158 vs. 0.68 ± 0.0291, <i>p</i> &lt; 0.01).</AbstractText>
          <AbstractText Label="DISCUSSION AND CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggested that FAEE could be used to ameliorate osteoporosis by the MAPK signalling pathway, suggesting that FAEE could be a potential therapeutic candidate for osteoporosis.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Ming-Yue</ForeName>
            <Initials>MY</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Technology, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>An</LastName>
            <ForeName>Meng-Fei</ForeName>
            <Initials>MF</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Science, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fan</LastName>
            <ForeName>Mao-Si</ForeName>
            <Initials>MS</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Technology, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Shao-Shi</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Technology, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Ze-Rui</ForeName>
            <Initials>ZR</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Food Science and Technology, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Yun-Li</ForeName>
            <Initials>YL</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Provincial Center for Research &amp; Development of Natural Products; School of Chemical Science and Technology, Yunnan University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xiang</LastName>
            <ForeName>Ze-Min</ForeName>
            <Initials>ZM</Initials>
            <AffiliationInfo>
              <Affiliation>College of Science, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sheng</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Key Laboratory of Pu-erh Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>College of Science, Yunnan Agricultural University, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Kunming, P. R. China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D002109">Caffeic Acids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>5B8915UELW</RegistryNumber>
          <NameOfSubstance UI="C099085">ethyl ferulate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002109" MajorTopicYN="N">Caffeic Acids</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010010" MajorTopicYN="N">Osteoclasts</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010012" MajorTopicYN="N">Osteogenesis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015663" MajorTopicYN="N">Osteoporosis, Postmenopausal</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010052" MajorTopicYN="N">Ovariectomy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067996" MajorTopicYN="N">RAW 264.7 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Ferulic acid ethyl ester</Keyword>
        <Keyword MajorTopicYN="N">osteoclast</Keyword>
        <Keyword MajorTopicYN="N">postmenopausal osteoporosis</Keyword>
      </KeywordList>
      <CoiStatement>There are no conflicts to declare in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>18</Day>
          <Hour>17</Hour>
          <Minute>8</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35180021</ArticleId>
        <ArticleId IdType="pmc">PMC8865110</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2022.2039216</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Adamopoulos IE, Mellins ED.. 
2015. Alternative pathways of osteoclastogenesis in inflammatory arthritis. Nat Rev Rheumatol. 11(3):189–194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4346500</ArticleId>
            <ArticleId IdType="pubmed">25422000</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Al-Daghri NM, Aziz I, Yakout S, Aljohani NJ, Al-Saleh Y, Amer OE, Sheshah E, Younis GZ, Al-Badr FBM.. 
2017. Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis. Medicine. 96(4):e5780–e5785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5287950</ArticleId>
            <ArticleId IdType="pubmed">28121926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ang E, Liu Q, Qi M, Liu HG, Yang X, Chen H, Zheng MH, Xu J.. 
2011. Mangiferin attenuates osteoclastogenesis, bone resorption, and RANKL-induced activation of NF-κB and ERK. J Cell Biochem. 112(1):89–97.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20683903</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banu J, Varela E, Fernandes G.. 
2012. Alternative therapies for the prevention and treatment of osteoporosis. Nutr Rev. 70(1):22–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22221214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biver E, Chopin F, Coiffier G, Brentano TF, Bouvard B, Garnero P, Cortet B.. 
2012. Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Joint Bone Spine. 79(1):20–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21724445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolling BW, Li LJ, Lee CH, Parkin KL.. 
2011. Dietary supplementation of ferulic acid and ferulic acid ethyl ester induces quinone reductase and glutathione-S-transferase in rats. Food Chem. 124(1):1–6.</Citation>
        </Reference>
        <Reference>
          <Citation>Boutros T, Chevet E, Metrakos P.. 
2008. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol Rev. 60(3):261–310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18922965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyce BF, Xing L, Franzoso G, Siebenlist U.. 
1999. Required and nonessential functions of nuclear factor-kappa B in bone cells. Bone. 25(1):137–139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10423039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boyle WJ, Simonet WS, Lacey DL.. 
2003. Osteoclast differentiation and activation. Nature. 423(6937):337–342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12748652</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casarrubios L, Matesanz MC, Sánchez-Salcedo S, Arcos D, Vallet-Regí M, Portolés MT.. 
2016. Nanocrystallinity effects on osteoblast and osteoclast response to silicon substituted hydroxyapatite. J Colloid Interface Sci. 482:112–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27497232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Zhu G, Hao L, Wu M, Ci H, Li YP.. 
2013. C/EBPα regulates osteoclast lineage commitment . Proc Natl Acad Sci U S A. 110(18):7294–7299.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3645589</ArticleId>
            <ArticleId IdType="pubmed">23580622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen CL, Liu FL, Lee CC, Chen TC, Ahmed Ali AA, Sytwu HK, Chang DM, Huang HS.. 
2014. Modified salicylanilide and 3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives as novel inhibitors of osteoclast differentiation and bone resorption. J Med Chem. 57(19):8072–8085.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25200306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Zhi X, Pan P, Cui J, Cao L, Weng W, Zhou Q, Wang L, Zhai X, Zhao Q, et al. . 
2017. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. Faseb J. 31(11):4855–4865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5636701</ArticleId>
            <ArticleId IdType="pubmed">28739641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chung HJ, Kim WK, Oh J, Kim MR, Shin JS, Lee J, Ha IH, Lee SK.. 
2017. Anti-osteoporotic activity of harpagoside by upregulation of the BMP2 and WNT signaling pathways in osteoblasts and suppression of differentiation in osteoclasts. J Nat Prod. 80(2):434–442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28106392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clowes JA, Riggs BL, Khosla S.. 
2005. The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 208:207–227.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16313351</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Collin-Osdoby P, Osdoby P.. 
2012. RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol Biol. 816:187–202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22130930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cong Q, Jia H, Li P, Qiu S, Yeh J, Wang Y, Zhang ZL, Ao J, Li B, Liu H.. 
2017. p38α MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner. Sci Rep. 7:45964–45978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5382695</ArticleId>
            <ArticleId IdType="pubmed">28382965</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cummings SR, Bates D, Black DM.. 
2002. Clinical use of bone densitometry: scientific review. JAMA. 288(15):1889–1897.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12377088</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunha FVM, Gomes B. d S, Neto B. d S, Ferreira AR, de Sousa DP, de Carvalho e Martins M. d C, Oliveira F. d A.. 
2016. Ferulic acid ethyl ester diminished Complete Freund's Adjuvant-induced incapacitation through antioxidant and anti-inflammatory activity. Naunyn Schmiedebergs Arch Pharmacol. 389(1):117–130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26497184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darnay BG, Haridas V, Ni J, Moore PA, Aggarwal BB.. 
1998. Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J Biol Chem. 273(32):20551–20555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9685412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF.. 
2002. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci. 115(Pt 22):4317–4325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12376563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng X.
2005. RANKing intracellular signaling in osteoclasts. IUBMB Life. 57(6):389–395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16012047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galibert L, Tometsko ME, Anderson DM, Cosman D, Dougall WC.. 
1998. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem. 273(51):34120–34127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9852070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grassi F, Tell G, Robbie-Ryan M, Gao Y, Terauchi M, Yang X, Romanello M, Jones DP, Weitzmann MN, Pacifici R.. 
2007. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA. 104(38):15087–15092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1986617</ArticleId>
            <ArticleId IdType="pubmed">17848519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayman AR.
2008. Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity. 41(3):218–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18365835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, et al. . 
2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 114(4):475–484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC503767</ArticleId>
            <ArticleId IdType="pubmed">15314684</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikeda N, Sugiyama T, Suzuki T, Mukai K, Kusuhara S.. 
2012. Effects of β-cryptoxanthin on bone metabolism in a rat model of osteoporosis. J of Animal and Veterinary Advances. 11(1):30–35.</Citation>
        </Reference>
        <Reference>
          <Citation>Janas A, Folwarczna J.. 
2017. Opioid receptor agonists may favorably affect bone mechanical properties in rats with estrogen deficiency-induced osteoporosis. Naunyn Schmiedebergs Arch Pharmacol. 390(2):175–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5233738</ArticleId>
            <ArticleId IdType="pubmed">27896372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jee WS, Yao W.. 
2001. Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact. 1(3):193–207.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15758493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalu DN.
1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15(3):175–191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1773131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang SJ, Choi BR, Kim SH, Yi HY, Park HR, Song CH, Ku SK, Lee YJ.. 
2017. Anti-climacterium effects of pomegranate concentrated solutions in ovariectomized ddY mice. Exp Ther Med. 13(4):1249–1266.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5377405</ArticleId>
            <ArticleId IdType="pubmed">28413464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim EY, Kim JH, Kim M, Park JH, Sohn Y, Jung HS.. 
2020. Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro. J Ethnopharmacol. 257:112828–112860.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32268206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim JH, Kim M, Jung HS, Sohn Y.. 
2019. Leonurus sibiricus L. ethanol extract promotes osteoblast differentiation and inhibits osteoclast formation. Int J Mol Med. 44(3):913–926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6657961</ArticleId>
            <ArticleId IdType="pubmed">31524244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, et al. . 
1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397(6717):315–323.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9950424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kum C, Kim E, Kim J, Lee B, Min J, Heo J, Kim J, Yeo M, Soh Y, Jun H.. 
2017. Cyperus rotundus L. extract suppresses RANKL-induced osteoclastogenesis through NFATc1/c-fos downregulation and prevent bone loss in OVX-induced osteoporosis rat. J Ethnopharmacol. 205:186–194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28315458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuo TR, Chen CH.. 
2017. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 5:18–26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5436437</ArticleId>
            <ArticleId IdType="pubmed">28529755</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kwan Tat S, Padrines M, Théoleyre S, Heymann D, Fortun Y.. 
2004. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 15(1):49–60.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14746813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al. . 
1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 93(2):165–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9568710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee EJ, Kim JL, Kim YH, Kang MK, Gong JH, Kang YH.. 
2014. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice. Phytomedicine. 21(10):1208–1215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24932975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lelovas PP, Xanthos TT, Thoma SE, Lyritis GP, Dontas IA.. 
2008. The laboratory rat as an animal model for osteoporosis research. Comp Med. 58(5):424–430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2707131</ArticleId>
            <ArticleId IdType="pubmed">19004367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li F, Yang X, Bi J, Yang Z, Zhang C.. 
2016. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats. Pharm Biol. 54(9):1857–1864.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26760929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W, Li N, Tang Y, Li B, Liu L, Zhang X, Fu H, Duan JA.. 
2012. Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer. Bioorg Med Chem Lett. 22(19):6085–6088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22954735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liao S, Feng W, Liu Y, Wang Z, Ding X, Song F, Lin X, Song H, Kc A, Su Y, et al. . 
2021. Inhibitory effects of biochanin A on titanium particle-induced osteoclast activation and inflammatory bone resorption via NF-κB and MAPK pathways . J Cell Physiol. 236(2):1432–1444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32853427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manolagas SC.
2000. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev. 21(2):115–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10782361</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marchisio PC, Cirillo D, Naldini L, Primavera MV, Teti A, Zambonin-Zallone A.. 
1984. Cell-substratum interaction of cultured avian osteoclasts is mediated by specific adhesion structures. J Cell Biol. 99(5):1696–1705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2113372</ArticleId>
            <ArticleId IdType="pubmed">6436255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maruotti N, Grano M, Colucci S, d'Onofrio F, Cantatore FP.. 
2011. Osteoclastogenesis and arthritis. Clin Exp Med. 11(3):137–145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21069419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, Nogi Y.. 
2004. Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem. 279(44):45969–45979.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15304486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto M.. 
2000. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem. 275(40):31155–31161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10859303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, et al. . 
2000. Reciprocal role of ERK and NF kappaB pathways in survival and activation of osteoclasts. J Cell Biol. 148(2):333–342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2174281</ArticleId>
            <ArticleId IdType="pubmed">10648566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakamura H, Hirata A, Tsuji T, Yamamoto T.. 
2003. Role of osteoclast extracellular signal-regulated kinase (ERK) in cell survival and maintenance of cell polarity. J Bone Miner Res. 18(7):1198–1205.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12854829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orsal E, Halici Z, Bayir Y, Cadirci E, Bilen H, Ferah I, Aydin A, Ozkanlar S, Ayan AK, Seven B, et al. . 
2013. The role of carnitine on ovariectomy and inflammation-induced osteoporosis in rats. Exp Biol Med. 238(12):1406–1412.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24131539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pacifici R.
1996. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 11(8):1043–1051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8854239</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park B, Song HS, Kwon JE, Cho SM, Jang SA, Kim MY, Kang SC.. 
2017. Effects of Salvia miltiorrhiza extract with supplemental liquefied calcium on osteoporosis in calcium-deficient ovariectomized mice. BMC Complement Altern Med. 17(1):545–559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5738837</ArticleId>
            <ArticleId IdType="pubmed">29262817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pastoureau P, Chomel A, Bonnet J.. 
1995. Specific evaluation of localized bone mass and bone loss in the rat using Dual-Energy X-Ray absorptiometry subregional analysis. Osteoporosis Int. 5(3):143–149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7655173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pazianas M, Abrahamsen B.. 
2011. Safety of bisphosphonates. Bone. 49(1):103–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21236370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pengjam Y, Madhyastha H, Madhyastha R, Yamaguchi Y, Nakajima Y, Maruyama M.. 
2016. NF-κB pathway inhibition by anthrocyclic glycoside aloin is key event in preventing osteoclastogenesis in RAW264.7 cells. Phytomedicine. 23(4):417–428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27002412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phuong NT, Cuong TT, Quang DN.. 
2014. Anti-inflammatory activity of methyl ferulate isolated from Stemona tuberosa Lour. Asian Pac J Trop Med. 7:S327–S331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25312145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu SX, Dan C, Ding LS, Peng S, Chen SN, Farnsworth NR, Nolta J, Gross ML, Zhou P.. 
2007. A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chem Biol. 14(7):860–869.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17656322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rachner TD, Khosla S, Hofbauer LC.. 
2011. Osteoporosis: now and the future. Lancet. 377(9773):1276–1287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3555696</ArticleId>
            <ArticleId IdType="pubmed">21450337</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rachoń D, Vortherms T, Seidlová-Wuttke D, Wolfgang W.. 
2007. Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause. 14(5):925–932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17414092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakai E, Aoki Y, Yoshimatsu M, Nishishita K, Iwatake M, Fukuma Y, Okamoto K, Tanaka T, Tsukuba T.. 
2016. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo. Phytomedicine. 23(8):828–837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27288918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shaul YD, Seger R.. 
2007. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta. 1773(8):1213–1226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17112607</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song SH, Zhai YK, Li CQ, Yu Q, Lu Y, Zhang Y, Hua WP, Wang ZZ, Shang P.. 
2016. Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro. Bone Rep. 5:262–273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5440975</ArticleId>
            <ArticleId IdType="pubmed">28580395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sultana R.
2012. Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders. Biochim Biophys Acta. 1822(5):748–752.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22064438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takayanagi H.
2007a. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 7(4):292–304.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17380158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takayanagi H.
2007b. The role of NFAT in osteoclast formation. Ann N Y Acad Sci. 1116:227–237.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18083930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Teitelbaum SL, Ross FP.. 
2003. Genetic regulation of osteoclast development and function. Nat Rev Genet. 4(8):638–649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12897775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsai YC, Lee YM, Hsu CH, Leu SY, Chiang HY, Yen MH, Cheng PY.. 
2015. The effect of ferulic acid ethyl ester on leptin-induced proliferation and migration of aortic smooth muscle cells. Exp Mol Med. 47(8):e180–e188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4558489</ArticleId>
            <ArticleId IdType="pubmed">26315599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N, Singh D.. 
2012. Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS One. 7(9):e44552–e44564.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3438183</ArticleId>
            <ArticleId IdType="pubmed">22970248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wahba HMA, Al-Zahrany MSA.. 
2013. Effect of feeding on diets supplemented by some vegetable oils on blood lipids and bone mineral content in osteoporotic rats. Life Sci J. 10(1):1458–1465.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang MY, Shen C, An MF, Xie CQ, Wu X, Zhu QQ, Sun B, Huang YP, Zhao YL, Wang XJ, et al. . 
2018. Combined treatment with Dendrobium candidum and black tea extract promotes osteoprotective activity in ovariectomized estrogen deficient rats and osteoclast formation. Life Sci. 200:31–41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29544757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang RT, Xiong XY, Liu L, Zhang F, Zhao MG, Jia M, Li C, Mei QB.. 
2002. Inhibitive effect and mechanism of ethyl ferulate on platelet congregation induced by ADP. J Fourth Mil Med Univ. 23:537–539. Chinese</Citation>
        </Reference>
        <Reference>
          <Citation>Wang RT, Zhou SY, Zhang F, Liu LN, Liu ZG, Mei QB.. 
2004a. Protective effects of ethyl ferulate on injured vascular endothelial cells (EC) by H2O2. Chin Clin Pharmacol Ther. 9:763–765. Chinese</Citation>
        </Reference>
        <Reference>
          <Citation>Wang RT, Dai XL, Xia Q, Ma JQ, Mei QB.. 
2008. Protective effect of ethyl ferulate on acute pulmonary edema in rats. China Pharm. 19:1226–1227. Chinese</Citation>
        </Reference>
        <Reference>
          <Citation>Wang RT, Zhou SY, Zhang F, Wang HF, Mei QB.. 
2004b. Ethyl ferulate alleviation of CCl4-induced liver toxicity in mice. Chinese Pharmacol Bull. 20(10):1196–1197. Chinese</Citation>
        </Reference>
        <Reference>
          <Citation>Wang Y, Zhang X, Li L, Zhang Z, Wei C, Gong G.. 
2021. Ethyl ferulate contributes to the inhibition of the inflammatory responses in murine RAW 264.7 macrophage cells and acute lung injury in mice. PLoS One. 16(5):e0251578–e0251592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8153479</ArticleId>
            <ArticleId IdType="pubmed">34038447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang YG, Jiang LB, Gou B.. 
2017. Protective effect of vanillic acid on ovariectomy-induced osteoporosis in rats. Afr J Tradit Complement Altern Med. 14(4):31–38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5471479</ArticleId>
            <ArticleId IdType="pubmed">28638864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, et al. . 
2012. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. J Bone Miner Res. 27(6):1298–1308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22337253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu HH, Liu TT, Hu LH, Li J, Gan CX, Xu J, Chen F, Xiang ZM, Wang XJ, Sheng J.. 
2019. Effect of caffeine on ovariectomy-induced osteoporosis in rats. Biomed Pharmacother. 112:108650–108658.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30797144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X, Liang J, Wang Z, Su Y, Zhan Y, Wu Z, Li J, Li X, Chen R, Zhao J, et al. . 
2021. Sesamolin protects mice from ovariectomized bone loss by Inhibiting osteoclastogenesis and RANKL-mediated NF-κB and MAPK signaling pathways. Front Pharmacol. 12:664697–664710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8237092</ArticleId>
            <ArticleId IdType="pubmed">34194327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaidi M.
2007. Skeletal remodeling in health and disease. Nat Med. 13(7):791–801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17618270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang LW, Al-Suwayeh SA, Hsieh PW, Fang JY.. 
2010. A comparison of skin delivery of ferulic acid and its derivatives: Evaluation of their efficacy and safety. Int J Pharm. 399(1-2):44–51.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20692328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang R, Hu SJ, Li C, Zhang F, Gan HQ, Mei QB.. 
2012. Achyranthes bidentata root extract prevent OVX-induced osteoporosis in rats. J Ethnopharmacol. 139(1):12–18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21669273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao X, Wu ZX, Zhang Y, Yan YB, He Q, Cao PC, Lei W.. 
2011. Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats. J Ethnopharmacol. 137(3):1083–1088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21782010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Y, Zhu ZL, Guan XX, Hou WW, Yu HY.. 
2009. Reciprocal roles between caffeine and estrogen on bone via differently regulating cAMP/PKA pathway: The possible mechanism for caffeine-induced osteoporosis in women and estrogen's antagonistic effects. Med Hypotheses. 73(1):83–85.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19278793</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
